Skip to main content
BIIB
NASDAQ Life Sciences

Real-World Data Show 76% Slower Alzheimer's Progression on LEQEMBI

Tom Rudovsky · Reported by Wiseek News
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$249.28
Mkt Cap
$36.893B
52W Low
$160.365
52W High
$261
52W Position info
55% above low
Off High info
4.5% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

BIIB sits 55% above its 52-week low of $160.365 on light trading volume (0.2× avg).

Summary

Three-year real-world data from 560 patients across 13 U.S. sites found a 76% lower rate of progression to moderate or severe Alzheimer's dementia with LEQEMBI versus a matched natural history cohort. A separate meta-analysis covered roughly 5,000 patients, though the release gives no quantified outcome for it. This is retrospective, non-randomized evidence for an already-marketed drug, not a new approval or controlled-trial result, so it supports the commercial case rather than resetting it. Safety findings were consistent with ALZ-NET and the U.S. prescribing information, meaning no new safety signal. The data lands after a run of positive LEQEMBI news, including Japan's September approval of the subcutaneous autoinjector and Canada's August reimbursement recommendation.

At the time of this announcement, BIIB was trading at $249.28 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $36.9B. The 52-week trading range was $160.36 to $261.00. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

BIIB - Latest Insights

BIIB
Nov 17, 2026, 4:45 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $253.00
Real-time Price: $249.87 info
Change: -$3.13 (-1%) info
Market Cap: $36.891B info
BIIB
Nov 09, 2026, 1:02 AM EST
Source: Reuters
Importance Score:
8
Price at Filing: $248.35
Real-time Price: $249.87 info
Change: +$1.52 (+0.61%) info
Market Cap: $36.891B info
BIIB
Oct 28, 2026, 6:23 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $252.73
Real-time Price: $249.87 info
Change: -$2.86 (-1%) info
Market Cap: $36.891B info
BIIB
Oct 28, 2026, 6:07 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $252.73
Real-time Price: $249.87 info
Change: -$2.86 (-1%) info
Market Cap: $36.891B info
BIIB
Oct 28, 2026, 6:00 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $252.73
Real-time Price: $249.87 info
Change: -$2.86 (-1%) info
Market Cap: $36.891B info